๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Lipoprotein(a)

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events NCT07136012Phase 3252 sites๐Ÿ“ Alexander City๐Ÿ“ Birmingham๐Ÿ“ Birmingham Amgen ยท Tests: Olpasiran, Placebo Assessment of Lipoprotein(a) and Endogenous Fibrinolysis in Atherosclerotic Cardiovascular Disease/Aortic Valve Disease NCT06126367n/a1 site๐Ÿ“ Stevenage East and North Hertfordshire NHS Trust ยท Tests: Thrombotic assessment, Measurement of Lp(a) Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults NCT07575438Phase 21 site๐Ÿ“ Montreal May Faraj, PDt, PhD ยท Tests: Fish Oil, Fish Oil, Corn oil control Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia NCT06597019Phase 366 sites๐Ÿ“ San Francisco๐Ÿ“ San Francisco๐Ÿ“ Washington D.C. Novartis Pharmaceuticals ยท Tests: Inclisiran, Placebo A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis NCT05646381Phase 2140 sites๐Ÿ“ Huntsville๐Ÿ“ Beverly Hills๐Ÿ“ Beverly Hills Novartis Pharmaceuticals ยท Tests: Pelacarsen (TQJ230) 80mg, Matching placebo Impact of Implementation Strategies on Lp(a) Testing in Secondary Care Settings NCT07508007n/a1 site๐Ÿ“ Nuremberg Novartis Pharmaceuticals A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD) NCT07619820Phase 11 site๐Ÿ“ Beijing CSL Behring ยท Tests: CSL300, Placebo AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION) NCT07577609n/a1 site๐Ÿ“ Galway University of Galway Impact of the Corrie Lipids Digital Health Program on Lipid Optimization NCT07478887NA1 site๐Ÿ“ Baltimore Johns Hopkins University ยท Tests: Corrie Lipids Digital Health Program A Study of SRSD216 in Patients With Elevated Lipoprotein (a) NCT07172646Phase 1, Phase 21 site๐Ÿ“ Beijing Sirius Therapeutics Co., Ltd. ยท Tests: SRSD216 injection, Placebo A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004) NCT07614984Phase 276 sites๐Ÿ“ Alexander City๐Ÿ“ Mobile๐Ÿ“ Beverly Hills Merck Sharp & Dohme LLC ยท Tests: MK-7262, Enlicitide, Placebo for MK-7262, Placebo for enlicitide A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk NCT07613294Phase 358 sites๐Ÿ“ La Jolla๐Ÿ“ Northridge๐Ÿ“ Torrance Eli Lilly and Company ยท Tests: Lepodisiran, Placebo A Study of BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol๏ผˆLDL-C๏ผ‰ NCT07368608Phase 1, Phase 21 site๐Ÿ“ Changsha BeBetter Med Inc ยท Tests: BEBT-701 Injection, BEBT-701 Injection Placebo๏ผˆ0.9% Sodium Chloride Injection๏ผ‰ Atlantic Lipid Lowering Treatment Optimization Program NCT06439654NA2 sites๐Ÿ“ Clark๐Ÿ“ Springfield Atlantic Health System ยท Tests: Supportive care Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial NCT07293260Phase 340 sites๐Ÿ“ Bridgeport๐Ÿ“ Jacksonville๐Ÿ“ Overland Park Amgen ยท Tests: Olpasiran, Placebo Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels NCT06496243Phase 21 site๐Ÿ“ Philadelphia NewAmsterdam Pharma ยท Tests: obicetrapib 10 mg + obicetrapib/evolocumab 140 mg Q 2 weeks A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naรฏve Patients. NCT07619131Phase 3152 sites๐Ÿ“ Dothan๐Ÿ“ Chandler๐Ÿ“ Phoenix AstraZeneca ยท Tests: Laroprovstat, Rosuvastatin 1, Rosuvastatin 2, Laroprovstat/Rosuvastatin 1, Placebo to match rosuvastatin Metabolic Impact of VLCPUFA-Rich Fish Oil: A Clinical Study on Omega-3 Index Enhancement in Healthy Individuals NCT07882160NA1 site๐Ÿ“ Bethesda National Heart, Lung, and Blood Institute (NHLBI) ยท Tests: VLCPUFA-rich fish oil, DHA-rich fish oil Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study) NCT07359105NA2 sites๐Ÿ“ Seoul๐Ÿ“ Seoul Sin Gon Kim ยท Tests: Moderate-intensity statin monotherapy, Ezetimibe or ezetimibe-statin combination therapy Heart CT Imaging to Detect Early Coronary Artery Disease in First-Degree Relatives With High or Low Lipoprotein(a) Identified Through Family Screening NCT06995183n/a1 site๐Ÿ“ Amsterdam E.S.stroes A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease NCT06164730Phase 127 sites๐Ÿ“ Dothan๐Ÿ“ Pomona๐Ÿ“ Boca Raton Verve Therapeutics, Inc. ยท Tests: VERVE-102 Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients? NCT06471036NA1 site๐Ÿ“ Minneapolis Duke University ยท Tests: Care Champion Intervention Cardiovascular Risk in Children With Chronic Conditions Study NCT07086989n/a3 sites๐Ÿ“ Budapest๐Ÿ“ Budapest๐Ÿ“ Budapest Semmelweis University Low-carbohydrate Diet and Low-Density Lipoprotein - Cholesterol (LDL-c) Interindividual Variability NCT07675603NA1 site๐Ÿ“ Bath University of Bath ยท Tests: control diet, Low carbohydrate diet A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia NCT07619118Phase 345 sites๐Ÿ“ Sun City West๐Ÿ“ Gardena๐Ÿ“ Lomita AstraZeneca ยท Tests: laroprovstat/rosuvastatin 1, laroprovstat/rosuvastatin 2, laroprovstat/rosuvastatin 3, laroprovstat/rosuvastatin 4, Plaโ€ฆ Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia NCT06597006Phase 319 sites๐Ÿ“ San Francisco๐Ÿ“ Washington D.C.๐Ÿ“ St Louis Novartis Pharmaceuticals ยท Tests: Inclisiran, Placebo The Effect of Lipoprotein (a) on Arterial Stiffness, Endothelial Function and Myocardial Deformation NCT07324902n/a2 sites๐Ÿ“ Athens๐Ÿ“ Athens University of Athens Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LY NCT05962827NA2 sites๐Ÿ“ Nice๐Ÿ“ Nice Centre Hospitalier Universitaire de Nice ยท Tests: lipoprotein (a) A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C) NCT07428473Phase 13 sites๐Ÿ“ Clayton๐Ÿ“ Papatoetoe๐Ÿ“ Christchurch Monash University ยท Tests: STX-1150 Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing Polysorbate 80 Compared to the Currently Marketed Formulation NCT07626281Phase 16 sites๐Ÿ“ Lenexa๐Ÿ“ Lenexa๐Ÿ“ San Antonio Novartis Pharmaceuticals ยท Tests: Inclisiran formulation containing PS80, Currently marketed inclisiran formulation
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy